Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix.

Santin AD, Bellone S, Parrish RS, Coke C, Dunn D, Roman J, Theus JW, Cannon MJ, Parham GP, Pecorelli S.

Gynecol Obstet Invest. 2003;56(1):28-34. Epub 2003 Jul 14.

PMID:
12867765
2.

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.

Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

PMID:
12807246
3.

High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).

Niibe Y, Kenjo M, Onishi H, Ogawa Y, Kazumoto T, Ogino I, Tsujino K, Harima Y, Takahashi T, Anbai A, Tsuchida E, Toita T, Takemoto M, Yamashita H, Hayakawa K.

Jpn J Clin Oncol. 2010 Aug;40(8):795-9. doi: 10.1093/jjco/hyq053. Epub 2010 May 5.

PMID:
20444747
4.

Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.

Perez CA, Grigsby PW, Castro-Vita H, Lockett MA.

Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1275-88.

PMID:
7635767
5.

Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer.

Lim MC, Kim JY, Kim TH, Park S, Kong SY, Yoon JH, Kang S, Seo SS, Park SY.

Yonsei Med J. 2008 Dec 31;49(6):993-1003. doi: 10.3349/ymj.2008.49.6.993.

6.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330
7.

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome.

Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, Chassagne D.

Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1051-6.

PMID:
8262826
8.
10.

The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.

Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ.

Radiother Oncol. 2003 Apr;67(1):69-76.

PMID:
12758242
11.

Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.

Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):351-8.

PMID:
10030261
12.

High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.

Wang X, Liu R, Ma B, Yang K, Tian J, Jiang L, Bai ZG, Hao XY, Wang J, Li J, Sun SL, Yin H.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007563. doi: 10.1002/14651858.CD007563.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD007563.

PMID:
20614461
13.

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.

J Clin Oncol. 2004 Mar 1;22(5):872-80.

PMID:
14990643
14.

Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.

Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA.

Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):307-17. Erratum in: Int J Radiat Oncol Biol Phys 1999 Nov 1;45(4):1093.

PMID:
9607346
15.

Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Kokka F, Bryant A, Brockbank E, Powell M, Oram D.

Cochrane Database Syst Rev. 2015 Apr 7;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Review.

PMID:
25847525
16.

Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H.

Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1309-17.

PMID:
7635770
17.

Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: experience over ten years.

Han I, Orton C, Shamsa F, Hart K, Strowbridge A, Deppe G, Porter A, Chuba PJ.

Radiat Oncol Investig. 1999;7(5):289-96.

PMID:
10580898
18.

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.

Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, Portelance L, Crook J, Jones KD.

Cancer. 1999 Oct 15;86(8):1528-36.

PMID:
10526282
19.

Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e49-56. doi: 10.1016/j.ijrobp.2011.01.022. Epub 2011 Apr 4.

PMID:
21470794
20.

Supplemental Content

Support Center